- Home
- JG vs ARTV Comparison
JG vs ARTV Comparison
Compare JG & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JG
- ARTV
- Stock Information
- Founded
- JG 2012
- ARTV 2019
- Country
- JG China
- ARTV United States
- Employees
- JG N/A
- ARTV N/A
- Industry
- JG Computer Software: Programming Data Processing
- ARTV
- Sector
- JG Technology
- ARTV
- Exchange
- JG Nasdaq
- ARTV NYSE
- Market Cap
- JG 52.8M
- ARTV 61.9M
- IPO Year
- JG 2018
- ARTV 2024
- Fundamental
- Price
- JG $11.51
- ARTV $1.93
- Analyst Decision
- JG
- ARTV Strong Buy
- Analyst Count
- JG 0
- ARTV 7
- Target Price
- JG N/A
- ARTV $19.17
- AVG Volume (30 Days)
- JG 17.7K
- ARTV 147.5K
- Earning Date
- JG 05-29-2025
- ARTV 05-08-2025
- Dividend Yield
- JG N/A
- ARTV N/A
- EPS Growth
- JG N/A
- ARTV N/A
- EPS
- JG N/A
- ARTV N/A
- Revenue
- JG $46,938,193.00
- ARTV N/A
- Revenue This Year
- JG $10.90
- ARTV N/A
- Revenue Next Year
- JG N/A
- ARTV N/A
- P/E Ratio
- JG N/A
- ARTV N/A
- Revenue Growth
- JG 17.73
- ARTV N/A
- 52 Week Low
- JG $2.36
- ARTV $1.78
- 52 Week High
- JG $20.94
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- JG 67.64
- ARTV N/A
- Support Level
- JG $10.90
- ARTV N/A
- Resistance Level
- JG $9.72
- ARTV N/A
- Average True Range (ATR)
- JG 0.55
- ARTV 0.00
- MACD
- JG 0.24
- ARTV 0.00
- Stochastic Oscillator
- JG 84.42
- ARTV 0.00
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).